Clinical trial Recruiting at 1 site Observational Ages 18 and up

Hemorrhoid Artery Embolization (HAE) for Bleeding Internal Hemorrhoids: A Real-World Registry

Official title: Creation Of a Prospective Registry For Hemorrhoid Artery Embolization At The Joint & Vascular Institute

Run by Joint & Vascular Institute · NCT07635784 · Data updated 2026-11-12

This registry collects real-world data to see if hemorrhoid artery embolization helps adults with symptomatic internal hemorrhoids that haven’t improved with standard care.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment1200 (estimated)
SponsorJoint & Vascular Institute
Industry-sponsored
Locations1 site (Libertyville, Illinois)
StatusRecruiting
StartedJanuary 18, 2026
Main results expectedJanuary 2031
Study endsJanuary 2032
Registry record updatedJune 12, 2026
Trial IDNCT07635784 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18 years) with symptomatic internal hemorrhoids that bleed and have not responded to medical therapy, referred for HAE.

Probably not a fit

Patients with contraindications to embolization, non-bleeding hemorrhoids, or those who cannot consent or be followed for 36 months may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective registry records long-term outcomes of patients undergoing hemorrhoid artery embolization (HAE) for symptomatic internal hemorrhoidal bleeding. Participants are adults 18 and older who have not responded to medical therapy and are treated as part of routine care. Follow-up occurs at 1, 3, 6, 12, 18, 24, and 36 months to track bleeding, symptoms, and quality of life, with safety data collected per interventional radiology guidelines. There is no randomized control group; analyses will identify predictors of success and help refine patient selection and best practices for HAE. The study is observational and aims to understand real-world effectiveness and safety of HAE in this population.

Why it matters

Potential benefit: If successful, the registry could clarify who benefits most from HAE and improve patient selection and care pathways.

How similar studies have gone: Previous interventional studies suggest potential benefit of HAE, but evidence in a real-world registry context is still evolving; this registry aims to add real-world data.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults (≥18 years) with symptomatic bleeding internal hemorrhoids refractory to medical therapy, referred for HAE.

Exclusion Criteria:

* Pregnancy, coagulopathy, severe comorbidities, or inability to consent.

Where it's running

  • Joint and Vascular Institute
    Libertyville, Illinois, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.